Filing Details

Accession Number:
0000950170-23-072291
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-21 17:00:47
Reporting Period:
2023-12-18
Accepted Time:
2023-12-21 17:00:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783328 Tscan Therapeutics Inc. TCRX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1120355 J Timothy Barberich C/O Tscan Therapeutics, Inc.
830 Winter Street
Waltham MA 02451
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Acquisiton 2023-12-18 28,830 $4.89 66,710 No 4 P Direct
Voting Common Stock Acquisiton 2023-12-19 317 $4.97 67,027 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Voting Common Stock 33,259 Indirect By Barberich Family Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $4.63 to $5.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.